Brucella Serology and History of Brucellosis in Patients With Modic Changes Type 1
NCT04911283 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118
Last updated 2021-06-03
Summary
Objective: This study aims to examine Brucella serology and history of brucellosis in patients with lumbar Modic changes (MCs) type 1, considering results from cross-sectional and case-control comparisons.
Design: In comparative cross-sectional design, MCs type 1 patients (study group) and MCs type 2 patients (comparator group) were examined in terms of Brucella serology by using agglutination with Coombs test. In addition, in comparative case-control design, both of the MCs groups and age/sex-matched healthy controls were investigated for their medical history regarding brucellosis.
Conditions
- Brucellosis
- Spinal Degeneration
Interventions
- OTHER
-
Brucella serology test
MCs type 1 and type 2 patients were examined in terms of Brucella serology by using agglutination with Coombs test.
- OTHER
-
Medical history for brucellosis
Both of the MCs groups and healthy controls were investigated for their medical history regarding brucellosis.
Sponsors & Collaborators
-
Veysel Delen
lead OTHER
Principal Investigators
-
Veysel Delen · Mehmet Akif İnan Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-05-01
- Primary Completion
- 2020-07-01
- Completion
- 2020-07-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease
NCT02307513 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers
NCT05323110 ·Status: TERMINATED ·Phase: PHASE1
-
Gut Microbiota and Behcet's Syndrome: a Dietary Intervention Trial (MAMBA Study)
NCT03962335 ·Status: COMPLETED ·Phase: NA
-
MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASE
NCT01780363 ·Status: COMPLETED
-
MoMa Signature During Granulomatosis
NCT05916638 ·Status: RECRUITING
-
Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome
NCT05444946 ·Status: RECRUITING ·Phase: NA
-
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
NCT02291029 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis
NCT01363388 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
NCT00685373 ·Status: COMPLETED ·Phase: PHASE3
-
Nuclear Magnetic Resonance Spectroscopic Analysis of Urinary Metabolome in Sarcoidosis (RMN-SARCURINES)
NCT05181930 ·Status: COMPLETED
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease
NCT04369183 ·Status: COMPLETED
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Neurosarcoidosis : Initial Presentation and Disease Course
NCT04911348 ·Status: UNKNOWN
-
The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's Disease
NCT01720628 ·Status: COMPLETED
-
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
NCT00001350 ·Status: RECRUITING
-
IMPACT_BD (IMProving AdherenCe to Treatment in Behçet's Disease)
NCT05128357 ·Status: UNKNOWN
-
(PROSPECTOR) Screening Study Evaluating the Prevalence of the KIT D816V Mutation in Patients With Systemic Mast Cell Activation
NCT04811365 ·Status: COMPLETED
-
Cyclosporine Vs Steroids in DRESS
NCT04988256 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
NCT01302860 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Sacroiliac Joint Injection on Bone Marrow Edema
NCT04895228 ·Status: UNKNOWN ·Phase: NA
-
Biocollection of Patients With ANCA Associated Vasculitis
NCT05364892 ·Status: RECRUITING ·Phase: NA
-
Withdrawal of Colchicine in Behçet Syndrome
NCT06146192 ·Status: NOT_YET_RECRUITING
-
Characterization of the Fungal Origins in the Autoimmune Polyendocrinopathy of Type 1 Compared With the Autoimmune Polyendocrinopathies of Type 2
NCT03800056 ·Status: TERMINATED
-
ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients
NCT04462068 ·Status: COMPLETED